Blue Jays Re-Sign Max Scherzer to One-Year, $3MM Deal (+ Incentives)
Toronto Blue Jays fans have reason for cautious optimism as the team brings back veteran pitcher Max Scherzer on a one-year deal, according to reports surfacing on . The agreement, guaranteeing $3 million with the potential for up to $10 million in incentives, signals a continued belief in Scherzer’s ability to contribute despite a challenging season.
The move allows the Blue Jays to navigate roster complexities by placing outfielder Anthony Santander on the 60-day injured list. This financial maneuver underscores the team’s commitment to bolstering its pitching staff, even as it manages payroll considerations.
For Scherzer, this marks a return to a team he joined during the offseason, initially signing a $15.5 million contract. However, his first stint in Toronto was hampered by injury. Coming off a limited nine-start season with the Texas Rangers due to prior back surgery and a nerve issue in his throwing arm, Scherzer struggled to regain his dominant form.
The nerve issue proved persistent, forcing the Blue Jays to sideline him after just three innings in his debut due to thumb soreness. He didn’t return to the mound until late June, and even then, his performance fell short of expectations. Scherzer posted a career-worst 5.19 ERA over 85 innings, a stark contrast to the Cy Young-caliber numbers he’d consistently delivered throughout his illustrious 17-year career.
While his velocity remained respectable, averaging 93.6 mph, Scherzer’s effectiveness diminished as hitters made more consistent contact. He surrendered more than two home runs per nine innings for the first time in his career, placing him among the league leaders in that unfortunate category. Despite the statistical downturn, the Blue Jays clearly see value in Scherzer’s experience and potential.
The Blue Jays’ decision to re-sign Scherzer suggests a belief that he can benefit from a more structured workload and a carefully managed progression. The team is reportedly planning to utilize a six-man rotation, at least initially, to ease the burden on their starters, including Scherzer. This approach is partially necessitated by the injured list status of Shane Bieber, who is dealing with forearm fatigue following the playoff run.
The anticipated starting five – comprised of Dylan Cease, Kevin Gausman, Trey Yesavage, José Berríos, and Cody Ponce – will be bolstered by Scherzer’s presence, providing depth and a veteran option. Yesavage, in particular, will be under scrutiny as he enters his first full MLB season.
The six-man rotation, however, presents challenges for the bullpen. The resulting 13-pitcher limit will necessitate a smaller bullpen, placing increased importance on reliable long relievers like Eric Lauer. Lauer, an impending free agent, had expressed a desire for a starting role, but the addition of Scherzer likely diminishes those prospects.
Despite losing his arbitration case and being assigned the team’s desired $4.4 million salary, Lauer’s versatility will be valuable. The situation bears watching as the season approaches, as a healthy Lauer could potentially attract trade interest if he remains confined to a relief role.
Financially, the Scherzer signing pushes the Blue Jays’ luxury tax payroll to approximately $319 million, triggering a 90% tax rate on spending exceeding $304 million. The base salary accounts for a $2.7 million tax burden, with potential additional costs associated with any performance-based incentives Scherzer may earn. This demonstrates the team’s willingness to invest heavily in its pursuit of a championship.
The Blue Jays will be hoping Scherzer can recapture some of his former brilliance and provide a much-needed boost to the pitching staff. His playoff experience, highlighted by a strong performance in the postseason, further solidifies his value to the team. The success of this signing will hinge on Scherzer’s health and ability to adapt to a role that may require him to manage his innings carefully.